The Blood and Marrow Transplant (BMT) Program team performed 167 blood and marrow/stem cell/umbilical cord blood transplants in 2011. We performed 46 autologous transplants for non-Hodgkin lymphoma and 54 for multiple myeloma amyloidosis.
The most common disease indication for transplantation was myeloma/amyloidosis. This was followed by non-Hodgkin lymphoma, and Hodgkin's disease.
Our 100-day survival rate for autologous transplantation was 100 percent. Our 100-day survival rate for related ablative allogeneic transplantation was 100 percent.
Blood & Marrow Transplant | Accreditations
Foundation for the Accreditation of Cellular Therapy (FACT)
As a patient, FACT accreditation can assure you that the health care organization you choose is committed to quality patient care.
Blood & Marrow Transplant | Associations
Blood and Marrow Transplant Clinical Trials Network (CTN)
The Blood and Marrow Transplant Program collaborates with the BMT Clinical Trials Network (BMT CTN). BMT CTN was established because of a critical need for multi-institutional clinical trials focused directly on improving survival for patients undergoing hematopoietic cell transplantation (HCT).
Since 2001, the BMT CTN has opened more than 27 multi-institutional phase II and III trials, involved more than 100 transplant centers, and enrolled thousands of patients.
Graft vs. Host Disease - National Symposium (GvHD)
The Chronic GVHD Consortium is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different immune mediated disorders after allogeneic hematopoietic cell transplantation and improving the care of patients affected by these disorders.
Radiation Injury Treatment Network (RITN)
The RITN was developed to respond to a potential disaster resulting in mass casualties with marrow toxic injuries from ionizing radiation exposure or other hazardous material.
Southwest Oncology Group (SWOG)
SWOG is a cancer research cooperative group that designs and conducts multidisciplinary clinical trials to improve the practice of medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors.
Center for International Blood and Marrow Research (CIBMTR)
The Center for International Blood and Marrow Transplant Research (CIBMTR) collaborates with the global scientific community to advance hematopoietic cell transplantation (HCT) and cellular therapy research worldwide.
National Marrow Donor Program - Be The Match®
Our program has been an NMDP transplant center since December 1988. These statistics can help you understand the differences among transplant centers.
Progenitor Cell Processing Laboratory| Accreditations
College of American Pathologists (CAP)
The leading organization of board-certified pathologists fosters and advocates excellence in pathology and laboratory medicine worldwide.
Clinical Laboratories Improvement Amendment (CLIA)
The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing (except research) performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA).
Allogen Laboratories | Accreditations
American Society for Histocompatibility & Immunogenetics (ASHI)
The American Society for Histocompatibility and Immunogenetics is an international society of professionals dedicated to advancing the science, education, and application of immunogenetics and transplant immunology.
Blood Bank | Accreditations
American Association of Blood Banks (AABB)
AABB advances the practice and standards of transfusion medicine and cellular therapies to optimize patient and donor care and safety.
Cancer Answers & Appointments
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
- Outpatient appointment referrals: 216.444.7923 or 866.223.8100
- Inpatient hospital transfers: 800.553.5056
- Referring Physician Concierge: 216.444.6196 or 216.312.4910.
Search available cancer clinical trials by disease, hospital, phase or number.
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2015 Cleveland Clinic. All rights reserved.